Literature DB >> 16552557

Comparing the physiological and subjective effects of self-administered vs yoked cocaine in humans.

Eric C Donny1, George E Bigelow, Sharon L Walsh.   

Abstract

RATIONALE: Studies with laboratory animals demonstrating different effects of self- vs experimenter-administered drug suggest that the ability to control or predict drug delivery may be an important determinant of drug action.
OBJECTIVE: This study assessed whether self-administered and yoked cocaine injections produce different effects in humans.
METHODS: Ten inpatient volunteers with experience in using cocaine participated in a double-blind, yoked design during which four experimental test sessions were conducted. During two sessions, participants controlled if and when up to six 40 mg/70 kg i.v. cocaine injections were given. During two sessions, participants received noncontingent exposure to the same pattern of injections given during the preceding session (i.e., yoked) under blind conditions. Sessions followed a fixed-order, ABAB design. Measures of subjective and physiological response to cocaine were taken throughout each session.
RESULTS: Cardiovascular safety parameters were exceeded in some individuals after yoked, but not self-administered, cocaine resulting in some scheduled injections being delayed or withheld. Mean systolic and diastolic blood pressures were higher following yoked compared to self-administered cocaine. In contrast, analysis of the subjective effects revealed only small and generally nonsignificant differences in the effects of self-administered vs yoked cocaine.
CONCLUSIONS: These results suggest that under the laboratory methods employed, control over the schedule of drug delivery may not alter the subjective effects of cocaine in humans. In contrast, the cardiovascular effects of cocaine appear to be greater when the drug is administered noncontingently.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552557     DOI: 10.1007/s00213-006-0312-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Cardiovascular responses to cocaine self-administration: acute and chronic tolerance.

Authors:  S R Tella; C W Schindler; S R Goldberg
Journal:  Eur J Pharmacol       Date:  1999-10-21       Impact factor: 4.432

Review 2.  SYSTEMATIC EFFECT OF RANDOM ERROR IN THE YOKED CONTROL DESIGN.

Authors:  R M CHURCH
Journal:  Psychol Bull       Date:  1964-08       Impact factor: 17.737

Review 3.  Cardiovascular effects of cocaine in squirrel monkeys.

Authors:  S R Tella; C W Schindler; S R Goldberg
Journal:  NIDA Res Monogr       Date:  1991

4.  Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug.

Authors:  S I Dworkin; S Mirkis; J E Smith
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

Review 5.  Stress, behavior, and immunity: animal models and mediating mechanisms.

Authors:  M Borysenko; J Borysenko
Journal:  Gen Hosp Psychiatry       Date:  1982-04       Impact factor: 3.238

6.  Changes in dopamine oxidation currents in the nucleus accumbens during unlimited-access self-administration of d-amphetamine by rats.

Authors:  P. Di Ciano; C.D. Blaha; A.G. Phillips
Journal:  Behav Pharmacol       Date:  1996-11       Impact factor: 2.293

7.  Brain neurotransmitter turnover rates during rat intravenous cocaine self-administration.

Authors:  J E Smith; T R Koves; C Co
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

Review 8.  Cardiovascular disorders associated with cocaine use: myths and truths.

Authors:  Mark M Knuepfer
Journal:  Pharmacol Ther       Date:  2003-03       Impact factor: 12.310

9.  Assessing the initiation of cocaine self-administration in humans during abstinence: effects of dose, alternative reinforcement, and priming.

Authors:  Eric C Donny; George E Bigelow; Sharon L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2003-11-28       Impact factor: 4.530

10.  Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration.

Authors:  Garret D Stuber; Mitchell F Roitman; Paul E M Phillips; Regina M Carelli; R Mark Wightman
Journal:  Neuropsychopharmacology       Date:  2005-05       Impact factor: 7.853

View more
  6 in total

Review 1.  A qualitative and quantitative review of cocaine-induced craving: the phenomenon of priming.

Authors:  James J Mahoney; Ari D Kalechstein; Richard De La Garza; Thomas F Newton
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-01-31       Impact factor: 5.067

2.  Antiandrogen pretreatment alters cocaine pharmacokinetics in men.

Authors:  Rinah T Yamamoto; Christian J Teter; Tanya L Barros; Elissa McCarthy; Crystal Mileti; Trisha Juliano; Carissa L Medeiros; Alison Looby; Melissa A Maywalt; Jane F McNeil; David Olson; Gopinath Mallya; Scott E Lukas; Perry F Renshaw; Marc J Kaufman
Journal:  J Addict Med       Date:  2007-12       Impact factor: 3.702

Review 3.  Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.

Authors:  Ziva D Cooper; Rebecca M Craft
Journal:  Neuropsychopharmacology       Date:  2017-07-17       Impact factor: 7.853

4.  Threshold for the pleasurable effects of nicotine are lower than its reinforcing effects during self-administration.

Authors:  R Ross MacLean; Tore Eid; Suprit Parida; Ralitza Gueorguieva; Elise E DeVito; Mehmet Sofuoglu
Journal:  Exp Clin Psychopharmacol       Date:  2022-03-07       Impact factor: 3.492

5.  Cocaine cue versus cocaine dosing in humans: evidence for distinct neurophysiological response profiles.

Authors:  Malcolm S Reid; Frank Flammino; Bryant Howard; Diana Nilsen; Leslie S Prichep
Journal:  Pharmacol Biochem Behav       Date:  2008-07-11       Impact factor: 3.533

6.  Evidence for habitual and goal-directed behavior following devaluation of cocaine: a multifaceted interpretation of relapse.

Authors:  David H Root; Anthony T Fabbricatore; David J Barker; Sisi Ma; Anthony P Pawlak; Mark O West
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.